法国耐头孢他啶铜绿假单胞菌中产生的超广谱β-内酰胺酶、金属β-内酰胺酶和超广谱头孢菌素酶的全国性调查。
Nationwide investigation of extended-spectrum beta-lactamases, metallo-beta-lactamases, and extended-spectrum oxacillinases produced by ceftazidime-resistant Pseudomonas aeruginosa strains in France.
机构信息
Centre National de Référence de la Résistance aux Antibiotiques, Laboratoire associé P. aeruginosa, Hôpital Jean Minjoz, Besançon, France.
出版信息
Antimicrob Agents Chemother. 2010 Aug;54(8):3512-5. doi: 10.1128/AAC.01646-09. Epub 2010 Jun 14.
Abstract
A nationwide study aimed to identify the extended-spectrum beta-lactamases (ESBLs), metallo-beta-lactamases (MBLs), and extended-spectrum oxacillinases (ES-OXAs) in a French collection of 140 clinical Pseudomonas aeruginosa isolates highly resistant to ceftazidime. Six ESBLs (PER-1, n=3; SHV-2a, n=2; VEB-1a, n=1), four MBLs (VIM-2, n=3; IMP-18, n=1), and five ES-OXAs (OXA-19, n=4; OXA-28, n=1) were identified in 13 isolates (9.3% of the collection). The prevalence of these enzymes is still low in French clinical P. aeruginosa isolates but deserves to be closely monitored.
摘要
一项全国性研究旨在鉴定法国收集的 140 株对头孢他啶高度耐药的临床铜绿假单胞菌分离株中的超广谱β-内酰胺酶（ESBLs）、金属β-内酰胺酶（MBLs）和超广谱头孢菌素酶（ES-OXAs）。在 13 株菌（占该菌集的 9.3%）中鉴定出 6 种 ESBLs（PER-1，n=3；SHV-2a，n=2；VEB-1a，n=1）、4 种 MBLs（VIM-2，n=3；IMP-18，n=1）和 5 种 ES-OXAs（OXA-19，n=4；OXA-28，n=1）。法国临床铜绿假单胞菌分离株中这些酶的流行率仍然较低，但值得密切监测。
相似文献
1
Nationwide investigation of extended-spectrum beta-lactamases, metallo-beta-lactamases, and extended-spectrum oxacillinases produced by ceftazidime-resistant Pseudomonas aeruginosa strains in France.
Antimicrob Agents Chemother. 2010 Aug;54(8):3512-5. doi: 10.1128/AAC.01646-09. Epub 2010 Jun 14.
2
Extended-spectrum and metallo-beta-lactamases among ceftazidime-resistant Pseudomonas aeruginosa in Riyadh, Saudi Arabia.
J Chemother. 2012 Apr;24(2):97-100. doi: 10.1179/1120009X12Z.00000000015.
3
[Molecular epidemiology of beta-lactamases in ceftazidime-resistant Pseudomonas aeruginosa isolates].
Mikrobiyol Bul. 2015 Apr;49(2):156-65. doi: 10.5578/mb.8901.
4
Distribution of Ambler class A, B and D β-lactamases among Pseudomonas aeruginosa isolates.
Burns. 2012 Sep;38(6):855-60. doi: 10.1016/j.burns.2012.01.005. Epub 2012 Feb 19.
5
Determination of extended spectrum beta-lactamases, metallo-beta-lactamases and AmpC-beta-lactamases among carbapenem resistant Pseudomonas aeruginosa isolated from burn patients.
Burns. 2014 Dec;40(8):1556-61. doi: 10.1016/j.burns.2014.02.010. Epub 2014 Apr 22.
6
Molecular epidemiology of Pseudomonas aeruginosa clinical isolates from Korea producing β-lactamases with extended-spectrum activity.
Diagn Microbiol Infect Dis. 2014 Jul;79(3):373-7. doi: 10.1016/j.diagmicrobio.2014.03.007. Epub 2014 Mar 17.
7
Widespread detection of VEB-1-type extended-spectrum beta-lactamases among nosocomial ceftazidime-resistant Pseudomonas aeruginosa isolates in Sofia, Bulgaria.
J Chemother. 2007 Apr;19(2):140-5. doi: 10.1179/joc.2007.19.2.140.
8
Outbreak of PER-1 and diversity of β-lactamases among ceftazidime-resistant Pseudomonas aeruginosa clinical isolates.
J Med Microbiol. 2014 Mar;63(Pt 3):386-392. doi: 10.1099/jmm.0.069427-0. Epub 2014 Jan 7.
9
Challenging Antimicrobial Susceptibility and Evolution of Resistance (OXA-681) during Treatment of a Long-Term Nosocomial Infection Caused by a Pseudomonas aeruginosa ST175 Clone.
Antimicrob Agents Chemother. 2019 Sep 23;63(10). doi: 10.1128/AAC.01110-19. Print 2019 Oct.
10
Prospective survey of beta-lactamases produced by ceftazidime- resistant Pseudomonas aeruginosa isolated in a French hospital in 2000.
Antimicrob Agents Chemother. 2002 Sep;46(9):3031-4. doi: 10.1128/AAC.46.9.3031-3034.2002.
引用本文的文献
1
Antimicrobial Resistance in Romania: Updates on Gram-Negative ESCAPE Pathogens in the Clinical, Veterinary, and Aquatic Sectors.
Int J Mol Sci. 2023 Apr 26;24(9):7892. doi: 10.3390/ijms24097892.
2
A Plasmid Carrying in Belonging to a Novel Resistance Plasmid Family.
Microorganisms. 2022 Sep 17;10(9):1863. doi: 10.3390/microorganisms10091863.
3
Genetic Diversity, Biofilm Formation, and Antibiotic Resistance of Isolated from Cow, Camel, and Mare with Clinical Endometritis.
Vet Sci. 2022 May 16;9(5):239. doi: 10.3390/vetsci9050239.
4
Characterization of antibiotic resistance profiles in Pseudomonas aeruginosa isolates from burn patients.
Burns. 2021 Dec;47(8):1833-1843. doi: 10.1016/j.burns.2021.03.005. Epub 2021 Mar 17.
5
Mechanisms of Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa: Results of the GERPA Multicenter Study.
Antimicrob Agents Chemother. 2021 Jan 20;65(2). doi: 10.1128/AAC.01117-20.
6
High quality 3C de novo assembly and annotation of a multidrug resistant ST-111 Pseudomonas aeruginosa genome: Benchmark of hybrid and non-hybrid assemblers.
Sci Rep. 2020 Jan 29;10(1):1392. doi: 10.1038/s41598-020-58319-6.
7
Identification of Diverse Integron and Plasmid Structures Carrying a Novel Carbapenemase Among Species.
Front Microbiol. 2019 Mar 4;10:404. doi: 10.3389/fmicb.2019.00404. eCollection 2019.
8
Molecular epidemiology of Pseudomonas aeruginosa isolated from infected ICU patients: a French multicenter 2012-2013 study.
Eur J Clin Microbiol Infect Dis. 2019 May;38(5):921-926. doi: 10.1007/s10096-019-03519-w. Epub 2019 Mar 2.
9
A Comparative Study on Antibiotic Resistance of Klebsiella Strains from Surgical and Intensive Care Wards.
Curr Health Sci J. 2016 Apr-Jun;42(2):169-179. doi: 10.12865/CHSJ.42.02.09. Epub 2016 Jun 28.
10
A Review of SHV Extended-Spectrum β-Lactamases: Neglected Yet Ubiquitous.
Front Microbiol. 2016 Sep 5;7:1374. doi: 10.3389/fmicb.2016.01374. eCollection 2016.
本文引用的文献
1
Epidemiology of bacterial colonization at intensive care unit admission with emphasis on extended-spectrum beta-lactamase- and metallo-beta-lactamase-producing Gram-negative bacteria--an Indian experience.
J Med Microbiol. 2010 Aug;59(Pt 8):955-960. doi: 10.1099/jmm.0.018085-0. Epub 2010 Apr 22.
2
Hospital outbreak of Pseudomonas aeruginosa producing extended-spectrum oxacillinase OXA-19.
J Med Microbiol. 2010 Jul;59(Pt 7):866-869. doi: 10.1099/jmm.0.019364-0. Epub 2010 Mar 18.
3
Detection of a new extended-spectrum oxacillinase in Pseudomonas aeruginosa.
J Antimicrob Chemother. 2010 Feb;65(2):364-5. doi: 10.1093/jac/dkp438. Epub 2009 Dec 11.
4
Detection of the novel extended-spectrum beta-lactamase OXA-161 from a plasmid-located integron in Pseudomonas aeruginosa clinical isolates from Spain.
Antimicrob Agents Chemother. 2009 Dec;53(12):5288-90. doi: 10.1128/AAC.00822-09. Epub 2009 Sep 21.
5
Diversity, epidemiology, and genetics of class D beta-lactamases.
Antimicrob Agents Chemother. 2010 Jan;54(1):24-38. doi: 10.1128/AAC.01512-08. Epub 2009 Aug 31.
6
Emergence of extensive-drug-resistant Pseudomonas aeruginosa in a French university hospital.
Eur J Clin Microbiol Infect Dis. 2009 Oct;28(10):1217-22. doi: 10.1007/s10096-009-0767-8. Epub 2009 Jun 7.
7
[Emergence of extended-spectrum beta-lactamases in Pseudomonas aeruginosa: about 24 cases at Rouen University Hospital].
Pathol Biol (Paris). 2008 Nov-Dec;56(7-8):429-34. doi: 10.1016/j.patbio.2008.07.027. Epub 2008 Oct 4.
8
Beta-lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres).
J Antimicrob Chemother. 2008 Aug;62(2):316-23. doi: 10.1093/jac/dkn174. Epub 2008 May 8.
9
Molecular epidemiology of clinical Pseudomonas aeruginosa isolates carrying IMP-1 metallo-beta-lactamase gene in a University Hospital in Turkey.
Microb Drug Resist. 2007 Fall;13(3):191-8. doi: 10.1089/mdr.2007.748.
10
Incidence of class A extended-spectrum beta-lactamases in Champagne-Ardenne (France): a 1 year prospective study.
J Antimicrob Chemother. 2007 Nov;60(5):956-64. doi: 10.1093/jac/dkm319. Epub 2007 Sep 5.
Zotero 插件